Doz

Somatropin

سوماتروپین (هورمون رشد)

⚠ Unverified

🧬 Systemic Hormonal Preparations, Excl. Sex Hormones And InsulinsRecombinant growth hormone

🤰 Pregnancy:Use with caution🤱 Breastfeeding:Use with caution👶 Children:Use with caution👴 Older adults:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 FDA approved (BLA) BLA020280ATC H01AC01

Market / country: 🇺🇸 USA

Genotropin (US)

🧮 Dose calculator

Growth hormone deficiency and growth disorders (Turner, Prader-Willi, SGA, idiopathic short stature) · Regimen source: FDA Genotropin · 2FDA Genotropin · 2.1

⛔ GHD: 0.16–0.24 mg/kg/week; Prader-Willi: 0.24; SGA: up to 0.48; Turner: 0.33; idiopathic short stature: up to 0.47 mg/kg/week. Weekly dose split into 6 or 7 injections; never IV. Under a paediatric endocrinologist. FDA Genotropin · 2FDA Genotropin · 2.1

🛡️ Safety & information

Contraindications

  • ⛔ Acute critical illness; children with Prader-Willi who are severely obese or have severe respiratory impairment (sudden death); active malignancy; hypersensitivity; active proliferative or severe non-proliferative diabetic retinopathy; children with closed epiphyses. FDA Genotropin · 4

Warnings

  • • Neoplasms; impaired glucose tolerance and diabetes; intracranial hypertension; fluid retention; hypoadrenalism and hypothyroidism; slipped capital femoral epiphysis and scoliosis progression in children; pancreatitis. FDA Genotropin · 5

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Genotropin · 8.1

    “Risk Summary Limited available data with somatropin use in pregnant women are insufficient to determine a drug-associated risk of adverse developmental outcomes.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Genotropin · 8.2

    “Risk Summary There is no information regarding the presence of somatropin in human milk.”
  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Genotropin · 8.4

    “Safety and effectiveness of GENOTROPIN in pediatric patients have been established in growth failure due to Prader-Willi syndrome (PWS), growth failure in children born small for gestational age (SGA) with no catch-up growth by age 2 years, growth failure associated with Turner syndrome, idiopathic short stature (ISS) …”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Genotropin · 8.5

    “A lower starting dose and smaller dose increments should be considered for older patients [see Dosage and Administration (2.2) ].”
  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav